ANGELA TURNER: Open Payments
NPI 1457858250 · BARBOURVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 39 payments from 17 companies in 2025. Trend: 2023 $192 · 2024 $754 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $135 |
| Novartis Pharmaceuticals Corporation | 6 | $123 |
| ABBVIE INC. | 5 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $46 |
| Corcept Therapeutics | 2 | $40 |
| SANOFI-AVENTIS U.S. LLC | 2 | $37 |
| Dynavax Technologies Corporation | 2 | $33 |
| Novo Nordisk Inc | 2 | $30 |
| Baxter Healthcare | 1 | $28 |
Products named: LEQVIO, HETLIOZ, CAPLYTA, VRAYLAR, Jornay PM, Korlym, FANAPT, TZIELD.
Industry payments across KY — which companies pay providers there.
